Author

Nicholas S. Ball

Dow Chemical (United States)ORCID 0009-0004-3074-8447Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Approach:statistical model· 1

Frequent Co-Authors

Fred A. WrightiD· 1 shared Han-Hsuan Doris TsaiiD· 1 shared Hannah M. Roe· 1 shared Ivan RusyniD· 1 shared Weihsueh A. ChiuiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Fred A. WrightORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A Systematic Analysis of Read-Across Adaptations in Testing Proposal Evaluations by the European Chemicals Agency

Hannah M. Roe, Han-Hsuan Doris Tsai, Nicholas S. Ball, Fred A. Wright, Weihsueh A. Chiu, Ivan Rusyn

This study systematically evaluates 1,538 ECHA decisions on read-across adaptations in REACH testing proposals, finding that 49% were accepted with group read-across having higher acceptance odds.

bioRxiv · Aug 29, 2024 · PreprintPharmacology & Toxicology